(E) Left panel - number (Y-axis) of high cytoplasmic/low nuclear EHD2 (red) and low cytoplasmic /high nuclear EHD2 (yellow) cases (among the 271 cases analyzed in D) within the luminal A (ER+/PR+, HER2- and Ki67 <14%), luminal B (ER+/PR+ or – and either HER2+ or Ki67 >/=14% or both), HER2-Enriched (ER-, PR- and HER2+, regardless of the Ki67) and TNBC (ER, PR and HER2-, regardless of the Ki67) BC subtypes. This evidence concerns the gene ERBB2 and breast cancer.